You are using an outdated browser. Please upgrade your browser to improve your experience.
Become a Fellow
ACP offers a number of resources to help members make sense of the MOC requirements and earn points.
Understanding MOC Requirements
Earn MOC points
The most comprehensive meeting in Internal Medicine.
April 11-13, 2019
Internal Medicine Meeting 2019
Prepare for the Certification and Maintenance of Certification (MOC)
Exam with an ACP review course.
Board Certification Review Courses
MOC Exam Prep Courses
Treating a patient? Researching a topic? Get answers now.
Visit AnnalsLearn More
Visit MKSAP 17 Learn More
Visit DynaMed Plus
Ensure payment and avoid policy violations. Plus, new resources to help you navigate the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Access helpful forms developed by a variety of sources for patient charts, logs, information sheets, office signs, and use by practice administration.
ACP advocates on behalf on internists and their patients on a number of timely issues. Learn about where ACP stands on the following areas:
© Copyright 2018 American College of Physicians. All Rights Reserved. 190 North Independence Mall West, Philadelphia, PA 19106-1572
Toll Free: (800) 523.1546 · Local: (215) 351.2400
Author: Richard J. VanDam, Wayne State
University School of Medicine, Class of 2011
Introduction: Hemodynamic Depression (HD) is a
worrisome complication following Carotid Artery Stenting (CAS).
Prophylactic atropine helps mitigate the risk of post-stent
bradycardia. We assessed the hypothesis that pre-operative systolic
BP and prophylactic atropine use are predictive for post-CAS
Methods: Using a single-center prospective CAS
registry, we retrospectively reviewed Electronic Medical Records of
109 patients (mean age 72 ±10 years; 68% men) receiving
successful CAS between December, 2008 and October, 2010. Of these,
45 patients received prophylactic atropine intra-operatively prior
to CAS deployment. Post-CAS HD was defined as symptomatic or
asymptomatic hypotension (SBP < 90 mmHg or drop >40%),
bradycardia (HR < 60 bpm or drop > 20%), or intra-operative
need for vasopressors or anticholinergics post-CAS as surrogate
end-points for hypotension and bradycardia respectively.
Statistical significance was determined using Student t-test (mean
± SEM) or ?2 for categorical variables (% incidence) and 95%
Results: Mean SBP decreased from baseline
following CAS deployment (156±2 to 125±3, p <
0.001, n=109) with a small increase in mean HR (70+1 to
72±1, p=0.03, n=109). The incidence of post-CAS hypotension
(n=24), bradycardia (n=38), and both (n=12) was 22%, 35%, and 11%
respectively. Drug intervention with either atropine (n=20),
dopamine (n=16), or both (n=6) was required in 42 patients for
post-CAS HD. Prophylactic atropine was associated with decreased
incidence of post-CAS bradycardia (29% vs. 58%, p < 0.01) but
increased incidence of hypotension (49% vs. 22%, p < 0.01),
leading to no net benefit in preventing HD (73% vs. 64%, p=0.31).
While pre-procedural hypertension (SBP=140 mmHg, n=54 of 109) was
not predictive of HD overall (p=0.12), it was a risk factor among
atropine-treated patients for post-CAS hypotension (65% vs. 25%, p
< 0.01) but not bradycardia (p=0.38). Conclusion: In conclusion,
atropine prophylaxis carried an increased risk of post-CAS
hypotension. While atropine mitigates the risk of post-CAS
bradycardia, the concomitant prophylactic use of vasopressors may
be warranted to offset the increased risk of hypotension-
particularly in patients presenting with elevated SBP immediately
prior to the procedure.
November Issue of IMpact